246 related articles for article (PubMed ID: 34905269)
1. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
[TBL] [Abstract][Full Text] [Related]
2. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
[TBL] [Abstract][Full Text] [Related]
3. Beyond prevention: Unveiling the benefits of triple vaccination on COVID-19 severity and resource utilization in solid organ transplant recipients.
Zhang JR; Johnson JC; Preble RG; Mujtaba M; Lea AS; Stevenson HL; Kueht M
Transpl Immunol; 2024 Jun; 84():102048. PubMed ID: 38641149
[TBL] [Abstract][Full Text] [Related]
4. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
Aslam S; Adler E; Mekeel K; Little SJ
Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256
[TBL] [Abstract][Full Text] [Related]
5. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
Hall VG; Al-Alahmadi G; Solera JT; Marinelli T; Cardinal H; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Matelski J; Humar A; Kumar D
Transplantation; 2022 Aug; 106(8):1622-1628. PubMed ID: 35502801
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
Subramanian V
J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
[TBL] [Abstract][Full Text] [Related]
9. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
Saharia KK; Husson JS; Niederhaus SV; Iraguha T; Avila SV; Yoo YJ; Hardy NM; Fan X; Omili D; Crane A; Carrier A; Xie WY; Vander Mause E; Hankey K; Bauman S; Lesho P; Mannuel HD; Ahuja A; Mathew M; Avruch J; Baddley J; Goloubeva O; Shetty K; Dahiya S; Rapoport AP; Luetkens T; Atanackovic D
Clin Transl Immunology; 2022; 11(5):e1391. PubMed ID: 35505864
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
Mazuecos A; Villanego F; Zarraga S; López V; Oppenheimer F; Llinàs-Mallol L; Hernández AM; Rivas A; Ruiz-Fuentes MC; Toapanta NG; Jiménez C; Cabello S; Beneyto I; Aladrén MJ; Rodríguez-Benot A; Canal C; Molina M; Pérez-Flores I; Saura IM; Gavela E; Franco A; Lorenzo I; Galeano C; Tabernero G; Pérez-Tamajón L; Martín-Moreno PL; Fernández-Girón F; Siverio O; Labrador PJ; De Arriba G; Simal F; Cruzado L; Moina I; Alcalde G; Sánchez-Álvarez E; Pascual J; Crespo M;
Transplantation; 2022 Jul; 106(7):1430-1439. PubMed ID: 35384924
[TBL] [Abstract][Full Text] [Related]
13. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
[TBL] [Abstract][Full Text] [Related]
14. The effect of COVID 19 vaccination on kidney recipients.
Marzieh L; Elahe P; Habib R; Maryam P; Arefeh J; Elnaz E; Sanaz D
Transpl Immunol; 2022 Oct; 74():101658. PubMed ID: 35777613
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study.
Heldman MR; Kates OS; Safa K; Kotton CN; Georgia SJ; Steinbrink JM; Alexander BD; Hemmersbach-Miller M; Blumberg EA; Crespo MM; Multani A; Lewis AV; Eugene Beaird O; Haydel B; La Hoz RM; Moni L; Condor Y; Flores S; Munoz CG; Guitierrez J; Diaz EI; Diaz D; Vianna R; Guerra G; Loebe M; Rakita RM; Malinis M; Azar MM; Hemmige V; McCort ME; Chaudhry ZS; Singh P; Hughes K; Velioglu A; Yabu JM; Morillis JA; Mehta SA; Tanna SD; Ison MG; Tomic R; Candace Derenge A; van Duin D; Maximin A; Gilbert C; Goldman JD; Sehgal S; Weisshaar D; Girgis RE; Nelson J; Lease ED; Limaye AP; Fisher CE;
Am J Transplant; 2021 Aug; 21(8):2774-2784. PubMed ID: 34008917
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
Giannella M; Pierrotti LC; Helanterä I; Manuel O
Transpl Int; 2021 Oct; 34(10):1776-1788. PubMed ID: 34450686
[TBL] [Abstract][Full Text] [Related]
17. Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients.
Almaghrabi RS; Alhamlan FS; Dada A; Al-Tawfiq JA; Al Hroub MK; Saeedi MF; Alamri M; Alhothaly B; Alqasabi A; Al-Qahtani AA; Al-Omari A; Alshukairi AN
J Infect Public Health; 2022 Jan; 15(1):51-55. PubMed ID: 34906898
[TBL] [Abstract][Full Text] [Related]
18. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
[TBL] [Abstract][Full Text] [Related]
19. Risk of severe COVID in solid organ transplant recipient.
Barreiro P; Candel FJ; Carretero MM; San Román J
Rev Esp Quimioter; 2023 Nov; 36 Suppl 1(Suppl 1):15-17. PubMed ID: 37997864
[TBL] [Abstract][Full Text] [Related]
20. A single-center review of pre-exposure prophylaxis with tixagevimab-cilgavimab in solid organ transplant recipients.
Morado F; Davoudi R; Kawewat-Ho P; Nanda N; Cartus R; Shaikh SA
Transpl Infect Dis; 2023 Aug; 25(4):e14086. PubMed ID: 37314092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
